Literature DB >> 2171691

Pharmacokinetics and tissue distribution of 99mTc-labelled enoxaparin in the rat: evaluation of dosimetry parameters.

N Colas Linhart1, M D Laforest, F Guiraud-Vitaux, I Gardin, A Petiet, J L Berthelot, B Bok.   

Abstract

A low molecular weight heparin, enoxaparin, was labelled with 99mTc and the characteristics of the labelled compound determined. In vitro the stability, and labelling efficiency (98%) of the labelled drug were excellent. Rats were injected with 99mTc-enoxaparin to study pharmacokinetics and distribution. The results were used to calculate dosimetric estimates which are a prerequisite for pharmacokinetic studies on labelled LMWH (low molecular weight heparin) in human subjects. Biodistribution studies showed preferential liver and spleen accumulation. But the doses absorbed by these target organs remained below the upper limits of the dose received by a patient undergoing hepatic scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171691     DOI: 10.1016/0753-3322(90)90135-v

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

Review 1.  Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease.

Authors:  S Noble; D H Peters; K L Goa
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

2.  Atraumatic Splenic Rupture in a Patient on Apixaban and Dual Antiplatelet Therapy.

Authors:  Piruthiviraj Natarajan; Sudhagar Thangarasu; Lela Ruck; Paul Estrada; Mahesh Gajendran; Gowri Renganathan; Bharat Ved Prakash; Olufemi Aduroja
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.